Sugi Predict

Sugi Predict / Compounds / SCHEMBL5780260

SCHEMBL5780260

SCHEMBL5780260

N#CCc1ccc(CN2C(=O)c3c(NC(=O)c4ccc(Cl)s4)cccc3C2O)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 3/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ F10 P00742 4/20 0.41
▸ STK33 Q9BYT3 1/20 0.38
▸ NPC1 O15118 4/20 0.34
▸ LMNA P02545 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ HTT P42858 1/20 0.34
▸ ACKR3 P25106 1/20 0.34
▸ KMT2A Q03164 6/20 0.33
▸ KDM4E B2RXH2 4/20 0.33
▸ MEN1 O00255 4/20 0.33
▸ RAB9A P51151 3/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ ESRRG P62508 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ PRSS12 P56730 1/20 0.33
▸ CASP3 P42574 1/20 0.32
▸ SENP8 Q96LD8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3377662 0.89 HPGD (0.44) HPGDALDH1A1SMN1; SMN2F10STK33
SCHEMBL5785459 0.86 F10 (0.43) HPGDALDH1A1SMN1; SMN2F10STK33
SCHEMBL3381006 0.84 F10 (0.45) HPGDALDH1A1SMN1; SMN2F10STK33
SCHEMBL5781704 0.81 F10 (0.45) HPGDALDH1A1SMN1; SMN2F10STK33
SCHEMBL3979217 0.81 HPGD (0.40) HPGDALDH1A1SMN1; SMN2F10MAPT
SCHEMBL5781798 0.80 F10 (0.49) HPGDALDH1A1SMN1; SMN2F10STK33
SCHEMBL6407633 0.79 ALDH1A1 (0.38) HPGDALDH1A1SMN1; SMN2F10STK33
SCHEMBL5784018 0.79 ALDH1A1 (0.38) HPGDALDH1A1SMN1; SMN2F10STK33
SCHEMBL5784023 0.79 ALDH1A1 (0.38) HPGDALDH1A1SMN1; SMN2F10STK33
SCHEMBL5780264 0.78 LMNA (0.33) HPGDNPC1LMNAMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1408962-B1 SUBSTITUTED ISOINDOLES AND THE USE THEREOF BAYER HEALTHCARE AG (DE) 2006-03-15 — — EP disclosed
US-6933295-B2 Substituted isoindoles and the use thereof BAYER AKTIENGESELLSCHAFT (DE) 2005-08-23 — — US disclosed
US-20050004207-A1 Nitrogen compounds such as N-(2-{4-[2-Amino-2-(hydroxyimino)ethyl]benzyl}-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl)-5-chloro-2-thiophenecarboxamide, used as blood-coagulation factor Xa antogonists for prophylaxis of cardiovascular disorders BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2005-01-06 — — US disclosed
EP-1408962-A1 SUBSTITUTED ISOINDOLES AND THE USE THEREOF Bayer HealthCare AG (DE) 2004-04-21 — — EP disclosed
WO-2003007942-A1 SUBSTITUTED ISOINDOLES AND THE USE THEREOF BAYER HEALTHCARE AG (DE) 2003-01-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004207-A1 Nitrogen compounds such as N-(2-{4-[2-Amino-2-(hydroxyimino)ethyl]benzyl}-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl)-5-chloro-2-thiophenecarboxamide, used as blood-coagulation factor Xa antogonists for prophylaxis of cardiovascular disorders F2, SERPINC1, F11 HPGD 25/4885ALDH1A1 1523/4885SMN1; SMN2 4230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.